Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus

Details for Australian Patent Application No. 2004273776 (hide)

Owner ViroNovative B.V. MedImmune, LLC

Inventors Osterhaus, Albertus Dominicus Marcellinus Erasmus; Tang, Roderick; Fouchier, Ronaldus Adrianus Maria; Van Den Hoogen, Bernadetta Gerarda; Haller, Aurelia

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004273776

PCT Pub. Number WO2005/027825

Priority 60/550,931 05.03.04 US; 60/466,181 25.04.03 US; 60/499,274 28.08.03 US

Filing date 23 April 2004

Wipo publication date 31 March 2005

Acceptance publication date 8 July 2010

International Classifications

A61K 39/155 (2006.01) Medicinal preparations containing antigens or antibodies - Paramyxoviridae, e.g. parainfluenza virus

C07K 14/115 (2006.01) Peptides having more than 20 amino acids

C07K 14/135 (2006.01) Peptides having more than 20 amino acids

C12N 15/44 (2006.01) Mutation or genetic engineering

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2005/027825 Priority application(s): WO2005/027825

9 October 2008 Alteration of Name

  The name of the applicant has been altered to ViroNovative B.V.; MedImmune, LLC

8 July 2010 Application Accepted

  Published as AU-B-2004273776

4 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004273779-Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof

2004273775-Methods for protection from toxicity of alpha emitting elements during radioimmunotherapy